Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) Stock Price, Quote & AI Analysis

Live ZNTL stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Zentalis Pharmaceuticals, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

Z
ZNTL
Zentalis Pharmaceuticals, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
3.850000
High
3.850000
Low
3.755000
Volume
86,500
VWAP
-
Market Cap
$92,333,379.84
52W Range
$1.13 - $6.95
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Aug 4, 2026 Q2
Market
EPS Estimate: $-0.4772
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Zentalis Pharmaceuticals, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Zentalis Pharmaceuticals, Inc. Common Stock Overview

Company information

Company Overview

Zentalis Pharmaceuticals, Inc. is a clinical oncology innovator developing an oral, non-chemotherapy, biomarker-driven treatment approach for ovarian cancer and multiple tumor types. The therapeutics development and biomarker expertise is advancing monotherapy and combination studies of its investigational potential first-in-class WEE1 inhibitor, azenosertib. It is focused on translating WEE1 science into clinical practice, aiming to equip physicians with a targeted, orally available medicine that enhances treatment experience, choice, and outcomes. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.

Company Details
Market Cap
$267.66M
Shares Outstanding
71,186,400
Weighted Shares Outstanding
72,135,453
CEO
Julia Marie Eastland
Address
10275 SCIENCE CENTER DRIVE, SAN DIEGO, CA, 92121
Phone
(858) 263-4333
Employees
166
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS
Listed
Apr 2020

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Zentalis Pharmaceuticals, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...